FDA Recalls Finder
News:
Site opened 3/25/2009. Welcome!
Home
Help
Search
Tags
Login
Register
FDA Recalls Finder
»
General Category
»
Press Releases From the FDA
»
FDA approves Erbitux to treat late-stage head and neck cancer
« previous
next »
Print
Pages: [
1
]
Author
Topic: FDA approves Erbitux to treat late-stage head and neck cancer (Read 42 times)
recalls-bot
Global Moderator
Hero Member
Posts: 1767
FDA approves Erbitux to treat late-stage head and neck cancer
«
on:
November 07, 2011, 05:14:19 PM »
FDA approves Erbitux to treat late-stage head and neck cancer
7 November 2011, 1:06 pm
The U.S. Food and Drug Administration today approved Erbitux (cetuximab) for use with chemotherapy to treat patients with late-stage (metastatic) head and neck cancer.
Source:
Food and Drug Administration--Press Releases
Logged
Print
Pages: [
1
]
« previous
next »
Tags:
FDA Recalls Finder
»
General Category
»
Press Releases From the FDA
»
FDA approves Erbitux to treat late-stage head and neck cancer
members